These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29037744)

  • 81. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
    Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
    J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
    [TBL] [Abstract][Full Text] [Related]  

  • 82. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA.
    Angerer V; Franz F; Moosmann B; Bisel P; Auwärter V
    Forensic Toxicol; 2019; 37(1):186-196. PubMed ID: 30636986
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.
    Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C
    Front Chem; 2019; 7():321. PubMed ID: 31157203
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings.
    Goncalves R; Labadie M; Chouraqui S; Peyré A; Castaing N; Daveluy A; Molimard M
    Clin Toxicol (Phila); 2022 Apr; 60(4):458-463. PubMed ID: 34850659
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
    Abouchedid R; Ho JH; Hudson S; Dines A; Archer JR; Wood DM; Dargan PI
    J Med Toxicol; 2016 Dec; 12(4):396-401. PubMed ID: 27456262
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014.
    Kaneko S
    Forensic Toxicol; 2017; 35(2):244-251. PubMed ID: 28706566
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.
    Paul ABM; Simms L; Amini S; Paul AE
    J Forensic Sci; 2018 Jul; 63(4):1321-1324. PubMed ID: 29194599
    [TBL] [Abstract][Full Text] [Related]  

  • 89. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
    Ford LT; Berg JD
    Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
    Freijo TD; Harris SE; Kala SV
    J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vivo detection of the new psychoactive substance AM-694 and its metabolites.
    Bertol E; Vaiano F; Di Milia MG; Mari F
    Forensic Sci Int; 2015 Nov; 256():21-7. PubMed ID: 26295909
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
    Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.
    Knittel JL; Holler JM; Chmiel JD; Vorce SP; Magluilo J; Levine B; Ramos G; Bosy TZ
    J Anal Toxicol; 2016 Apr; 40(3):173-86. PubMed ID: 26792810
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
    Erol Ozturk Y; Yeter O
    J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Aspects related to analysis and medico-legal assessment in the context of the presence of synthetic cannabinoids in biological material based on the example of AB-CHMINACA.
    Romańczuk A; Rojek S; Kula K; Kłys M
    Arch Med Sadowej Kryminol; 2018; 68(4):266-280. PubMed ID: 31025844
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
    Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
    West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.